Vivek Hattangadi

Rx Revolution: Pharma Leaders Choose Prescription Growth over Value Growth in LinkedIn Poll I recently threw out a question on LinkedIn for all pharma leaders: prescription growth or value sales? And guess what? The results were clear! Nearly 90% of respondents said prescription growth is king! This totally aligns with what my mentor, the amazing […]

Rise Above the Noise: The Zajonc Effect and Branding Excellence Robert Zajonc was a remarkable social psychologist from Poland. He was known for his extensive contributions to understanding human cognition. Later, he was Professor Emeritus of Psychology at Stanford University. He is well known for postulating the Zajonc Effect. The Zajonc Effect postulates that mere exposure effect

Medical Representatives: The Modern-Day Warriors of Pharma Marketing In the contemporary pharma business landscape, the role of a medical representative bears striking resemblance to that of an officer in the Armed Forces. Gone are the days when pharma prescription generation resulting into sales was perceived merely as transactions; today, it’s a battlefield where strategies are

Is Prompt Engineering Rocket Science? (Ref: Workshop-1 “WORLD PHARMA BRAND MANAGERS WEEK – 2024 on 20 January) This blog is in continuation of Workshop-1 during “WORLD PHARMA BRAND MANAGERS WEEK – 2024” culminating day. At the onset, my congratulations, and good wishes to all those who were present for Workshop # 1 “Medico-Marketing Copywriting 2.0:

What do great pharma leaders do? Well first-and-foremost, they get away from their offices and see what’s really going on in the organization. Great pharma leaders are in constant touch with internal and external customers! They get out of their air-conditioned offices. And along with the first-line leaders and the medical representatives, they sweat out

Déjà Vu, Déjà Do Something! Make UCPMP-2024 a Legislative Reality! Preamble In the landscape of pharmaceutical marketing ethics, the UCPMP (Uniform Code of Pharmaceutical Marketing Practices) has been a cornerstone, albeit with limited efficacy. The inception of UCPMP-2014 as a voluntary framework aimed to instil Good Marketing Practices within the Indian pharmaceutical industry, yet its

Bangladesh and India – The Biopharma Powerhouses: Conquering the Five Challenges Biopharmaceuticals, also known as biological medical products, represent the future of medical treatment in both Bangladesh and India, potentially serving as the cornerstone of the pharmaceutical industry in these regions. This class of medical products has made a profound impact on various medical fields,

Brand Life Cycle Management The Discovery of Novel Therapeutics Faces Challenges Discovering novel chemical entities, whether small molecules or biopharmaceutical entities has become increasingly challenging, with few promising candidates on the horizon. In India, the implementation of stricter patent laws has rendered the replication of existing drugs more difficult, eliminating the avenue of reverse engineering.

Is superior intelligence a requisite for pharma brand and sales management? (My IQ is just 112) Some years ago, there was a Mensa convention in San Francisco. Mensa, as you know, is an international organization for people who have an IQ of 140 or higher. Several of the Mensa members went out for lunch at

Go-to-Market or Go-to-Patient: The Evolving Strategy Preamble This post honors Mr. Sanjiv Navangul, who championed the “Go-To-Patient Strategy” for the pharmaceutical industry, a shift from the traditional “Go-To-Market” approach. He exemplifies putting theory into practice! In 1960, Harvard Business Review published Theodore Levitt’s groundbreaking article “Marketing Myopia,” which posed a critical question: “What business are